<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02852603</url>
  </required_header>
  <id_info>
    <org_study_id>2016LMC-2</org_study_id>
    <nct_id>NCT02852603</nct_id>
  </id_info>
  <brief_title>Study on Genetically Affected Sporadic Thoracic Aortic Aneurysm and Dissection</brief_title>
  <acronym>GenSTAND</acronym>
  <official_title>Study on Genetically Affected Sporadic Thoracic Aortic Aneurysm and Dissection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wuhan Asia Heart Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fu Wai Hospital, Beijing, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Wuhan Asia Heart Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Mortality of thoracic aortic aneurysm and dissection (TAAD) remains high because of the huge&#xD;
      blood lost from the aorta. Questions about the potentially genetic effects on sporadic TAAD&#xD;
      are raised by researchers to explore the possible mechanisms leading to sporadic TAAD and to&#xD;
      establish new clinical approaches to prevent TAAD-caused adverse clinical outcomes. This&#xD;
      study is intended to collect the gene information in sporadic TAAD patients and to explore&#xD;
      the relationship between genetic variation and the incidence of sporadic TAAD for further&#xD;
      study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Thoracic aortic dissection (TAD) is a critical clinical condition partly due to the rupture&#xD;
      of aortic aneurysm. Mostly, surgical treatment can reduce the symptoms and extend life span&#xD;
      of patients with thoracic aortic aneurysm and dissection (TAAD). However, mortality of TAAD&#xD;
      remains high because of the huge blood lost from the aorta. Sporadic TAAD was considered to&#xD;
      be a server consequence of hypertension, though most patients with hypertension won't have&#xD;
      TAAD as their final outcomes. Previous studies have revealed the associations between genetic&#xD;
      abnormalities and familial TAAD, and genetic tests have applied to assist the diagnosis of&#xD;
      certain TAAD. Therefore, the potentially genetic effects on sporadic TAAD are explored by&#xD;
      researchers to understand the possible mechanisms leading to sporadic TAAD and to establish&#xD;
      new clinical approaches to prevent TAAD-caused adverse clinical outcomes. This study is&#xD;
      intended to collect the gene information in sporadic TAAD patients and to explore the&#xD;
      relationship between genetic variation and the incidence of sporadic TAAD for further study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2014</start_date>
  <completion_date type="Actual">January 2020</completion_date>
  <primary_completion_date type="Actual">January 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Numbers of patients having thoracic aortic aneurysm and/or dissection are recorded. Diagnosis are confirmed by imaging analysis (CTA and/or Ultrasound) or by doctors during the operations.</measure>
    <time_frame>6 months</time_frame>
    <description>Arterial dissection actually happened</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">450</enrollment>
  <condition>Dissection of Aorta, Thoracic</condition>
  <condition>Aneurysm of Aorta, Thoracic</condition>
  <arm_group>
    <arm_group_label>thoracic aortic aneurysm and dissection</arm_group_label>
    <description>Patients with thoracic aortic aneurysm and/or dissection are recruited in the study.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Peripheral whole blood is obtained from patients. Serum, blood cell and DNA are separated and&#xD;
      stored for further study.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with thoracic aortic aneurysm and dissection.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with thoracic aortic aneurysm and dissection not due to trauma&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability of the patient, parent or guardian to give consent&#xD;
&#xD;
          -  Unwillingness to provide a blood specimen or participate in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xuan Zheng, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wuhan Asia Heart Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wuhan Asia Heart Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430022</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>July 27, 2016</study_first_submitted>
  <study_first_submitted_qc>August 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 2, 2016</study_first_posted>
  <last_update_submitted>April 11, 2021</last_update_submitted>
  <last_update_submitted_qc>April 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wuhan Asia Heart Hospital</investigator_affiliation>
    <investigator_full_name>Xuan Zheng</investigator_full_name>
    <investigator_title>vice director of laboratory of molecular cardiology</investigator_title>
  </responsible_party>
  <keyword>dissection</keyword>
  <keyword>aneurysm</keyword>
  <keyword>thoracic aorta</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm, Dissecting</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Thoracic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

